Cite
HARVARD Citation
Tang, Q. et al. (2022). Solamargine inhibits the growth of hepatocellular carcinoma and enhances the anticancer effect of sorafenib by regulating HOTTIP‐TUG1/miR‐4726‐5p/MUC1 pathway. Molecular carcinogenesis. 61 (4), pp. 417-432. [Online].